Activation of Peroxisome Proliferator-Activated Receptor γ Contributes to the Survival of T Lymphoma Cells by Affecting Cellular Metabolism
Authors:
- 1 February 2007
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 170 (2) , 722-732
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- GW9662, a potent antagonist of PPARγ, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPARγ agonist rosiglitazone, independently of PPARγ activationBritish Journal of Pharmacology, 2004
- T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulationNature Immunology, 2004
- Antineoplastic effects of peroxisome proliferatoractivated receptor γ agonistsThe Lancet Oncology, 2004
- PPARγ signaling exacerbates mammary gland tumor developmentGenes & Development, 2004
- Thiazolidinedione Activation of Peroxisome Proliferator-activated Receptor γ Can Enhance Mitochondrial Potential and Promote Cell SurvivalJournal of Biological Chemistry, 2002
- Activation of Peroxisome Proliferator-Activated Receptor-g Inhibits Apoptosis Induced by Serum Deprivation in LLC-PK1 CellsNephron Experimental Nephrology, 2002
- Prostaglandin D2, its metabolite 15‐d‐PGJ2, and peroxisome proliferator activated receptor‐γ agonists induce apoptosis in transformed, but not normal, human T lineage cellsImmunology, 2002
- Terminal Differentiation of Human Breast Cancer through PPARγMolecular Cell, 1998
- Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's LymphomaScience, 1994
- Isolation and Transmission of Human Retrovirus (Human T-Cell Leukemia Virus)Science, 1983